Clearbridge Investments, LLC Cara Therapeutics, Inc. Transaction History

Clearbridge Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.67 - $3.33 $44,194 - $88,125	-26,464 Reduced 2.65%	971,610 $1.63 Million
Q2 2023 Aug 11, 2023	BUY	$2.83 - $4.94 $1.45 Million - $2.53 Million	512,539 Added 105.56%	998,074 $2.82 Million
Q1 2023 May 12, 2023	BUY	$4.89 - $12.27 $375,537 - $942,299	76,797 Added 18.79%	485,535 $2.38 Million
Q4 2022 Feb 10, 2023	SELL	$8.88 - $12.77 $249,439 - $358,709	-28,090 Reduced 6.43%	408,738 $4.39 Million
Q3 2022 Nov 14, 2022	BUY	$8.24 - $12.56 $3.6 Million - $5.49 Million	436,828 New	436,828 $4.09 Million

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.